New Orleans - As the direction of cosmetic dermatology moves toward nonablative rejuvenation, physicians need to understand the current state of the science and continue to pursue new nonablative modalities, Robert A. Weiss, M.D., said.
Integrated Data From BRAVE-AA1 and BRAVE-AA2 Trials Supports Efficacy of Baricitinib Over 104 Weeks in Alopecia Areata
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Japanese Study Finds Patients With Alopecia Areata and Physicians Differ in Viewpoints of Severity and Treatment Satisfaction
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Answers to Top 3 Skin Performance Testing Questions
A New Role for Will Kirby, DO, FAOCD
2 Commerce Drive Cranbury, NJ 08512